Operative vs Non-Operative Treatment of Sacral Fractures

August 1, 2019 updated by: More Foundation

A Prospective, Randomized Controlled Trial Comparing Percutaneous Screw Fixation to Non-Operative Management for the Treatment of Sacral Fragility Fractures

The purpose of this study is to compare percutaneous trans-iliac trans-sacral screw fixation to non-operative management for the treatment of symptomatic, sacral fragility fractures in elderly patients.

Study Overview

Status

Unknown

Conditions

Detailed Description

Sacral fragility fractures cause significant pain and morbidity in the elderly population in which they occur. These low-energy pelvic injuries can cause prolonged immobility, long hospital stays, and requirement for higher levels of care.

Subjects will undergo a 48 hour period of physical therapy and pain management following identification of the sacral fracture.. If the subject has substantial pain or disability, the subject is eligible for enrollment in the RCT and randomization of 1:1 to one of two groups.

Group 1: Operative treatment: A single trans iliac trans sacral screw will be inserted at the sacral one or sacral two level based upon fracture location.

Group 2: Conservative (non-operative) treatment: Continued pain management and physical therapy advanced with weight bearing as tolerated.

The purpose of this study is to compare percutaneous trans-iliac trans-sacral screw fixation to non-operative management for the treatment of symptomatic, sacral fragility fractures in elderly patients.

Primary Objective: To compare the functional outcome and pain in elderly patients surgically treated compared to those non-operatively treated for sacral fractures.

Secondary Objective: To compare discharge disposition, length of stay in care facility post-discharge, complications, and need for ambulatory aid in elderly patients surgically treated compared to those non-operatively treated for sacral fractures.

Hypothesis: Subjects in the operative group will have improvement in functional outcome and pain at 2 weeks, higher likelihood of discharge to independent living, shorter stays in care facilities post-discharge, less complications, and less need for ambulatory aids.

Study Type

Interventional

Enrollment (Anticipated)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male or female patients ≥ 60 years of age
  2. Pelvic ring fractures classified as LC1 or sacral U, confirmed with plain radiographs, CT and/or MRI
  3. Fracture is the result of a low energy mechanism of injury or an insufficiency fracture without a precipitating event
  4. Onset of symptoms within four weeks of presentation to hospital
  5. Significant pain or disability determined by:

    1. Reported pain score ≥ 7 using the Visual Analogue Score (VAS) after a Timed "Up & Go" (TUG) test, or
    2. Inability to complete the TUG test
    3. Inability to get out of bed secondary to pain for 2 consecutive days

Exclusion Criteria:

  1. Vertically or rotationally unstable pelvic ring injuries
  2. Pathologic fracture secondary to tumor
  3. Non-ambulatory prior to injury
  4. Acute neurologic deficit
  5. High-energy mechanism of injury
  6. Concomitant lower extremity fractures affecting ambulation
  7. Presence of another injury or medical condition that prevents ambulation
  8. Presence of hardware or sacral morphology that prevents percutaneous sacral fixation
  9. Enrollment in another research study that precludes co-enrollment
  10. Inability to speak English
  11. Dementia with inability to answer questions and participate in study
  12. Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged patients without adequate support, etc.)
  13. Incarcerated or pending incarceration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Operative
A single trans-iliac, trans-sacral screw will be inserted at the sacral one or sacral two level.
A single trans-iliac, trans-sacral screw will be inserted at the sacral one or sacral two level based upon fracture location.
EXPERIMENTAL: Non-operative
Continued pain management and physical therapy
A single trans-iliac, trans-sacral screw will be inserted at the sacral one or sacral two level based upon fracture location.
Continued pain management and physical therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and Go (TUG) Test
Time Frame: 2 weeks
TUG Test
2 weeks
Sacral Region Pain
Time Frame: 2 weeks
Visual Analog Pain Scale, minimum score 0, maximum score 10, from no pain to worst possible pain
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Discharge Disposition Location
Time Frame: Up to 21 days
Location that subject was discharged to at hospital discharge: Home, Rehabilitation, Skilled Nursing Facility
Up to 21 days
Facility Length of Stay
Time Frame: Up to 21 days
Number of days in a rehabilitation or skilled nursing facility after hospital discharge
Up to 21 days
Ambulatory aid
Time Frame: 2 weeks
Use of walker, cane, or wheelchair
2 weeks
Complications
Time Frame: Up to 1 year
Screw migration, secondary surgery related to primary procedure, neurological deficit related to screw insertion, surgical site infection, wound dehiscence, deep infection, related re-admission, decubitus ulcer, pneumonia, deep vein thrombosis, pulmonary embolism, death
Up to 1 year
Patient Reported Health Outcome
Time Frame: Change from baseline to 1 year
Veterans Rand 12-item Health Survey (VR-12). This is a health related quality of life survey with 2 scores, Physical Component Score (PCS) including general health, physical functioning, physical role accomplishment, bodily pain and Mental Component Score (MCS) including role-emotional, vitality/mental health, social functioning. The results of the VR-12 are reported as 2 scores, MCS and PCS. The score range is 0-100 for each score, where a 0 score indicates the lowest level of health and a score of 100 indicates the highest level of health. The US population average PCS and MCS are both 50 points. The standard deviation is 10 points.
Change from baseline to 1 year
Patient Reported Outcome
Time Frame: Change from baseline to 1 year
Hip dysfunction and Osteoarthritis Outcome Score (HOOS), Total score of 0-100 with higher scores representing better function
Change from baseline to 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital length of stay
Time Frame: Up to 21 days
Number of days hospitalized
Up to 21 days
Narcotic use
Time Frame: 2 weeks
Use of narcotic pain medication, total in milligram equivalents
2 weeks
Healing
Time Frame: Change in healing from baseline to 1 year
Standard pelvic radiographs (AP, inlet, outlet, and lateral sacral views) will be performed to evaluate radiographic outcomes such as fracture healing, fixation failure, and fracture displacement.
Change in healing from baseline to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Clifford B Jones, MD, The CORE Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

August 1, 2019

Primary Completion (ANTICIPATED)

December 1, 2020

Study Completion (ANTICIPATED)

December 1, 2021

Study Registration Dates

First Submitted

April 30, 2019

First Submitted That Met QC Criteria

August 1, 2019

First Posted (ACTUAL)

August 5, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 5, 2019

Last Update Submitted That Met QC Criteria

August 1, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 3209

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sacral Fracture

Clinical Trials on Single screw fixation

Subscribe